Compare AbCellera Biologics Inc (ABCL) vs Albemarle Corp. (ALB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Albemarle Corp. — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while Albemarle Corp. trades at $131.06 (market cap $15.27B). The key difference: Albemarle Corp. is far larger — about 5.1× AbCellera Biologics Inc's market cap, and Albemarle Corp. pays a 1.27% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | ALB | |
|---|---|---|
Market Cap | $2.99B | $15.27B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $215.62 |
52-Week Low | $2.78 | $72.58 |
Enterprise Value | $2.58B | $17.75B |
Dividend Yield | — | 1.27% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →
